"Stavudine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
| Descriptor ID |
D018119
|
| MeSH Number(s) |
D03.383.742.680.705.875 D13.570.230.500.850 D13.570.230.855.875 D13.570.685.705.875
|
| Concept/Terms |
Stavudine- Stavudine
- D4T
- 2',3'-Didehydro-3'-deoxythymidine
- 2',3' Didehydro 3' deoxythymidine
- 2',3'-Didehydro-2',3'-dideoxythmidine
|
Below are MeSH descriptors whose meaning is more general than "Stavudine".
Below are MeSH descriptors whose meaning is more specific than "Stavudine".
This graph shows the total number of publications written about "Stavudine" by people in this website by year, and whether "Stavudine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stavudine" by people in Profiles.
-
Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana. J Int Assoc Physicians AIDS Care (Chic). 2012 Jul-Aug; 11(4):260-8.
-
Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children. J Int AIDS Soc. 2010 Aug 06; 13:31.
-
The benefit of supplementary feeding for wasted Malawian adults initiating ART. AIDS Care. 2010 Jun; 22(6):737-42.
-
Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children. Antivir Ther. 2010; 15(1):83-90.
-
Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients. J Infect Dis. 2002 Apr 15; 185(8):1070-6.
-
Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection. Antimicrob Agents Chemother. 2001 Mar; 45(3):758-63.
-
Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine. Pediatr Infect Dis J. 2000 Nov; 19(11):1083-6.
-
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). AIDS. 2000 Jul 28; 14(11):1591-600.
-
Excision of beta-D- and beta-L-nucleotide analogs from DNA by the human cytosolic 3'-to-5' exonuclease. Mol Pharmacol. 2000 May; 57(5):1051-5.
-
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy. Antimicrob Agents Chemother. 2000 Apr; 44(4):1029-34.